Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
There are several factors to consider. Depression is often more than a simple serotonin issue; neurotransmitters and mood are shaped by brain circuit dysfunction, chronic stress, inflammation, and hormone or diagnostic mismatches, which is why standard therapy or SSRIs may fall short.
New medical steps include personalized medication strategies (such as SNRIs or bupropion), ketamine or esketamine, TMS, targeted psychotherapy, and evidence-based lifestyle changes, but which to choose depends on your symptoms, history, and labs. See below for specific next steps, cautions, and when to seek urgent care.
If you still feel depressed despite trying therapy, medication, exercise, or lifestyle changes, you are not alone. Depression is complex. While many people hear that it is simply a "chemical imbalance," the reality is much more nuanced. Neurotransmitters and mood are closely connected—but they are only part of the story.
Understanding what may actually be happening in your brain and body can help you take smarter, more effective next steps.
Neurotransmitters are chemical messengers in your brain. They help nerve cells communicate with each other. Several key neurotransmitters are strongly linked to mood regulation:
For years, depression was explained mainly as a serotonin deficiency. That idea led to the development of SSRIs (selective serotonin reuptake inhibitors). While these medications help many people, we now know that neurotransmitters and mood regulation are far more complex than a single chemical imbalance.
Depression can involve:
So if treatment hasn't worked yet, it does not mean you are broken. It may mean your depression has multiple drivers.
If you are still struggling, one or more of these factors may be at play:
Research shows depression affects brain networks, not just individual neurotransmitters. Areas that regulate emotion, decision-making, and reward can become less connected or overactive in unhealthy patterns.
In some people, dopamine dysfunction—not serotonin—is the dominant issue. This can cause:
If this sounds familiar, your doctor may consider treatments that target dopamine or norepinephrine instead of only serotonin.
Long-term stress increases cortisol. Over time, elevated stress hormones can:
Even if the stressful situation has ended, your nervous system may still be in "survival mode." Treatment may need to focus on calming and retraining the stress response—not just adjusting medication.
Growing evidence shows that inflammation can interfere with neurotransmitters and mood.
Inflammation can:
Inflammation can stem from:
For some people, addressing physical health improves mood significantly.
Hormones and neurotransmitters work closely together.
Mood symptoms may worsen with:
If depression feels resistant to treatment, basic lab testing may uncover a medical contributor.
Depression is not one-size-fits-all. Different subtypes respond differently to treatment.
Examples include:
If your diagnosis is incomplete, treatment may miss the mark.
If traditional approaches haven't worked, there are newer evidence-based options worth discussing with a doctor.
Options may include:
These strategies aim to better balance neurotransmitters and mood pathways.
Ketamine-based treatments target glutamate rather than serotonin. They work differently from traditional antidepressants and can improve symptoms rapidly in some people with treatment-resistant depression.
They are typically used under medical supervision when other treatments have failed.
TMS uses magnetic pulses to stimulate specific brain regions involved in mood regulation. It is non-invasive and FDA-approved for treatment-resistant depression.
This approach focuses on restoring healthy brain circuit activity—not just altering neurotransmitter levels.
While lifestyle advice can sound simplistic, certain changes have strong scientific support for improving neurotransmitters and mood:
These are not quick fixes—but they enhance medical treatment.
Cognitive Behavioral Therapy (CBT), trauma-focused therapy, and newer modalities like EMDR and ACT can physically change brain connectivity over time.
Therapy works alongside medication to improve how neurotransmitters and mood networks function together.
If you're unsure whether what you're experiencing is depression—or something overlapping—it may help to step back and review your symptoms.
You might consider taking a free AI-powered symptom checker for depression to help you organize and better understand what you're experiencing before speaking with a healthcare professional.
This is not a diagnosis, but it can guide a more productive conversation with your doctor.
While many depression symptoms can be managed over time, some situations require immediate medical care.
Seek urgent help or speak to a doctor right away if you experience:
These are medical emergencies—not personal failures.
If you are still depressed, it does not mean:
It may mean your condition involves multiple layers: brain circuits, stress hormones, inflammation, genetics, trauma history, or misaligned treatment.
Neurotransmitters and mood are deeply interconnected—but they are part of a larger biological and psychological system.
The good news? Medicine now understands depression far better than it did even a decade ago. New therapies target brain networks, inflammation, and glutamate pathways—not just serotonin.
Most importantly: speak to a doctor about persistent depression, especially if symptoms are severe, worsening, or affecting your safety. Depression is a medical condition. It deserves proper care.
You are not failing treatment. You may simply need a more complete plan.
(References)
* Leonard, B. E., & Zifa, E. (2021). Revisiting the monoamine hypothesis of depression: evidence for a role of the noradrenergic and serotonergic systems in stress-induced depression. _European Neuropsychopharmacology_, _42_, 83-95.
* Lener, M., & Iosifescu, D. V. (2020). Beyond Monoamines: Glutamate and GABA in Depression. _Focus (American Psychiatric Publishing)_, _18_(4), 384-393.
* Miller, A. H., Nudelman, K. N., & Raison, C. L. (2019). Neuroinflammation in major depressive disorder: a review of the evidence and future directions. _Brain, Behavior, and Immunity_, _79_, 1-13.
* Zarate, C. A., Jr., Brutsche, N. E., & Lener, M. (2021). Ketamine and Esketamine: New Antidepressants with Novel Mechanisms. _Psychiatry Clinics of North America_, _44_(1), 123-143.
* Malhi, G. S., Mann, J. J., & Malhi, M. S. (2021). The neurobiology of major depressive disorder: a narrative review. _Australian & New Zealand Journal of Psychiatry_, _55_(10), 957-972.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.